Yakakwira bundu mutoro, immunotherapy, KEYTRUDA, Pembrolizumab, TMB-H

Pembrolizumab yakabvumidzwa kushandiswa mune chero kenza ine hosha yakakura yekuchinja mutoro

Chikunguru 2021: Iyo US Chikafu uye Medication Administration (FDA) yakawedzera zvinongedzo zvepembrolizumab (Keytruda), mushonga we immunotherapy, kusanganisa chero gomarara rine mutoro wakakura wekuchinja (TMB-H). Mvumo itsva ndeye f..

2018 ASCO musangano wegore, ASCO musangano, cetuximab, erbitux, focal rutapudzo, HNSCC, Pabosini

Pabosini pamwe necetuximab yekurapa kenza yemusoro nemutsipa ne70% yekudzikisira

Zvinoenderana nemhedzisiro yakaziviswa pamusangano wepagore we2018 ASCO, iyo CDK4/6 inhibitors pabociclib (Ibrance) uye cetuximab (Erbitux) yakasanganiswa kurapwa kweplatinamu-inodzivirira uye HPV-yakasununguka inodzokororwa / metastatic musoro uye ne.

nitrosonornicotinine, kusvuta, fodya-yakatarwa nitrosamines

E-e-fodya uye fodya yakajairika inosanganiswa nekenza yemuromo

Pamusangano we96th weInternational Association for Dental Research (IADR), Benjamin Chaffee weYunivhesiti yeCalifornia, San Francisco akaburitsa mushumo nezve nicotine uye carcinogens mufodya.

EphB4-ephrin-B2 inhibitor kurapwa, Tekinoroji nyowani

Nzira nyowani dzekurwisa dzokororo musoro nemutsipa kenza

Kunyangwe nekuvhiyiwa, radiotherapy, chemotherapy, uye / kana jeni-yakanangwa kurapa (senge cetuximab), makore mashanu ekupona kwecancer yemusoro nemutsipa wekanzuru ingori 46% chete. Kazhinji, kurapwa kwakanaka pakutanga, asi iyo ..

Mafuta eCitrus anogona kubatsira kubvisa yakaoma muromo zviratidzo zvinokonzerwa nemwaranzi kurapwa mumusoro nemutsipa kenza

Zvinoenderana neongororo nyowani yeStanford University Chikoro cheMishonga, mukomboni unowanikwa mumafuta emucitrus unogona kubatsira kudzikamisa muromo wemuromo zviratidzo zvinokonzerwa neradiotherapy kurapwa mumusoro nemutsipa kenza varwere. Iwo maseru emafuta ecitrus peel ari ..

Nivolumab yakabatanidzwa neipilimumab ndiyo yekutanga kurapwa kwakabudirira kwekenza yemusoro nemutsipa

Mune varwere vane metastatic malignant melanoma, kusanganiswa kweipilimumab (CTLA4 antibody) uye chirongwa chakafa (PD) -1 inhibitor nivolumab inogona kuvandudza zvakanyanya fungidziro ichienzaniswa ne monotherapy. Kubva pane izvi ..

Kutsvakurudza kufambira mberi kwechirwere chisingawanzo-musoro uye mutsipa kenza zvinodhaka

Inofananidzwa nemamwe mamota anorwadza senge isiri-diki kenza yemapapu kenza (NSCLC) uye kenza yemazamu, musoro nemutsipa squamous cell carcinoma (HNSCC) haina kujairika muUnited States. Kune angangoita mazana mashanu ezviitiko pasi rese eac ..

Vanogona varwere vane gomarara remusoro nemutsipa vanogona kunakirwa nehari inopisa inopisa panguva yekurapwa kweproton?

Mr. Xu munhu chaiye Chongqing chizvarwa. Iye zvakasikwa zvinonaka uye haana mufaro. Pakati pezvose zvinonaka, Chongqing poto inopisa inopisa ndiyo yaanofarira. Nekudaro, zvinosuruvarisa kuti, bundu rakaipa rine parotidhi gland yakawanikwa, iri ty ..

Kutaura kwePD-L1 muCTC yevarwere vane musoro uye mutsipa squamous cell carcinoma inosanganisirwa nekufungidzira.

Yunivhesiti yeAthens Strati A et al. yakataura kuti kunyangwe PD-L1 yakanyanyiswa mukutenderera kwemaseru maseru (CTC) inogona kupa ruzivo rwakanyanya uye rwakakosha rwekuzivisa varwere vane musoro uye mutsipa squamous cell ..

Ndezvipi zvinhu zvinokanganisa kuvhiyiwa kwegomarara remusoro nemutsipa? Vanachiremba vanotendeukira kukurapa kwekunyaradza here?

Chirevo chaKershena Liao weBaylor College yeMedicine muUnited States uye vanonzwisisa zvizere maitiro evatungamiriri vezvirwere zvemusoro nemutsipa vachifunga nezvekuchinja kurapwa, izvo zvinogona kubatsira kugadzirisa iyi yakaoma p ..